pmid,title,journal,year,drug,disease
40474339,An Exploratory Research to Evaluate the 30 Most Common Pulmonary Embolism Drugs in the Food and Drug Administration Adverse Event Reporting System.,The clinical respiratory journal,2025,Baricitinib,Breast Cancer
38216005,Properties of FDA-approved small molecule protein kinase inhibitors: A 2024 update.,Pharmacological research,2024,Baricitinib,Breast Cancer
36903483,Oral Bioactive Self-Nanoemulsifying Drug Delivery Systems of Remdesivir and Baricitinib: A Paradigmatic Case of Drug Repositioning for Cancer Management.,"Molecules (Basel, Switzerland)",2023,Baricitinib,Breast Cancer
36403719,Properties of FDA-approved small molecule protein kinase inhibitors: A 2023 update.,Pharmacological research,2023,Baricitinib,Breast Cancer
34921994,Properties of FDA-approved small molecule protein kinase inhibitors: A 2022 update.,Pharmacological research,2022,Baricitinib,Breast Cancer
33513356,Properties of FDA-approved small molecule protein kinase inhibitors: A 2021 update.,Pharmacological research,2021,Baricitinib,Breast Cancer
31862477,Properties of FDA-approved small molecule protein kinase inhibitors: A 2020 update.,Pharmacological research,2020,Baricitinib,Breast Cancer
28749581,Prediction of Transporter-Mediated Drug-Drug Interactions for Baricitinib.,Clinical and translational science,2017,Baricitinib,Breast Cancer
